Organization
Stichting Tools, Patient Research Partner, Amsterdam, Netherlands
1 abstract
Abstract
BIMEKIZUMAB TREATMENT RESULTED IN CLINICALLY MEANINGFUL IMPROVEMENTS IN THE PSORIATIC ARTHRITIS IMPACT OF DISEASE-12 (PSAID-12) SCORES USING POOLED RESULTS FROM TWO PHASE 3 TRIALS IN PATIENTS WITH PSORIATIC ARTHRITISOrg: Sorbonne Université, N/A, Paris, France, AP-HP, Pitié-Salpêtrière Hospital, N/A, Paris, France, Oxford University Hospitals NHS Trust, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Diseases, University of Oxford and Oxford Biomedical Research Centre, Oxford, United Kingdom, Johns Hopkins University School of Medicine, Division of Rheumatology, Baltimore, United States of America, Stichting Tools, Patient Research Partner, Amsterdam, Netherlands,